Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.


AFIAS is the platform of choice that uses blood or swabs to detect the presence of both Covid-19 IgG/IgM antibodies and Covid-19 Ag in suspected patients at the point of need, when time matters and a quantitative or semi-quantitative measurement is required. Ideal for the combo usage with VitaPCR to generate a unique bundle capable of providing a detailed picture of the patient status of illness in every decentralised setting, including those in hard to reach areas.

  • The AFIAS platform is scalable: it consists of two devices: AFIAS 1, which can handle one test at a time, and AFIAS 6, which allows 6 samples to be examined at the same time. 
  • The same platform can also be used to perform both serological antibody tests, detecting the presence and measuring the quantity of IgM and IgG antibodies in a patient’s blood sample and for checking the presence of the antigen, namely a specific viral protein.
  • The cartridge is fully automated and requires little nor work from an operator (lab-on-a-cartridge) 


AFIAS COVID-19 Ag is an automatic fluorescence Immunoassay (FIA) for the qualitative/semi-quantitative detection of novel corona virus (eg, SARS-CoV-2, 2019-nCoV) in human nasopharyngeal swab. It is useful as an aid in management and monitoring of SARS-CoV-2 infection (COVID-19).


AFIAS COVID-19 Ab test

AFIAS COVID-19 Ab is an automatic fluorescence Immunoassay(FIA) for the qualitative/semi-quantitative determination of IgG/IgM antibodies against 'Novel Coronavirus' in human whole blood/serum/plasma. It is helpful as an aid in the screening of early mild, asymptomatic or acute patients for identification of 'Novel Coronavirus (eg, SARS, 2019-nCoV)' infection with high sensitivity. Finger blood (peripheral blood; whole blood) using the unique 'all-in-one' tube, allows the patient's pain to blood collection to be relatively low and suitable for large-scale screening in the field.